SKB500
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SKB500, covering 2025-12-08 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: SKB500 Combinations in Patients With Small Cell Lung Cancer [Phase 2]